...years. To the extent, however, that such a reduction is the result of a compromise between the different interest groups involved, the Administration will...patented invention solely for uses reasonably related 163 -iito the development and submission of information needed for Federal regulatory review would...

...years. To the extent, however, that such a reduction is the result of a compromise between the different interest groups involved, the Administration will...the bill would add a new paragraph (e) to section 27l of title 35, dealing with patent infringement. Specifically, this section would provide that the...

...Finally Section 202 provides that it shall not be an act of patent infringement to make, use, or sell a patented invention solely for uses reasonably related to the development and submission of information under federal Law which regulates the manufacture, use or sale of drugs. The hearings brought...

...Essentially those provisions stated that it would not be an act of infringement to make, use, or to sell a patented invention solely for uses reasonably related to the development and submission of information under a Federal law which regulates the manufacture, use, or sale of drugs. We recommend...

...Essentially, those provisions stated that it would not be an act of infringement to make, use or sell a patented invention solely for uses reasonably related to the development and submission of information under a federal law which regulates the manufacture, use or sale of drugs. a product is...

...those provisions stated that it would not be an act of infringement to make, use or to sell a - 24 patented invention solely for uses reasonably related to the development and submission of information under a federal law which regulates the manufacture, use or sale of drugs. If a product...

...patented inventions in the development of pharmaceuticals. It is not an act of patent infringement to use a patented invention solely for uses reasonably related to the development and submission of information under a federal law that regulates the use of drugs.46-3 The Federal Food, Drug, and Cosmetic...

...that the safe harbor provisions of 35 USC § 271(e)(1), which exempt from patent infringement the use of a patented invention "solely for uses reasonably related to the development and submission of information" to the Food and Drug Administration (FDA), extend to experiments using patented drugs...

...infringement to make, use, offer to sell, or sell within the United States or import into the United States a patented invention . . . solely for uses reasonably related to the development and submission of information under a Federal law which regulates the manufacture, use, or sale of drugs or veterinary...

...Hatch-Waxman Act provides generally that "[i]t shall not be an act of infringement to make, use, or sell a patented invention * * * solely for uses reasonably related to the development and submission of information under a Federal law which regulates the manufacture, use, or sale of drugs." 35 USCA §271(e)(1)....